The auto injector market represents a rapidly expanding segment within the global pharmaceutical delivery systems industry, driven by the increasing prevalence of chronic diseases and the growing ...
Klaus Brinkrode, Sales Manager of Med. Tech Device Assembly & Labeling at Syntegon, explains their RMA machine and how it improves auto-injector assembly. The RMA is being used for R&D and small batch ...
YORK, Pa., Aug. 30, 2011 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced the development of a unique proprietary range of auto-injectors for ...
Dublin, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The "Epinephrine Auto-Injection Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Epinephrine ...
AstraZeneca announced it has received FDA approval for the self-administration of benralizumab in a prefilled, single-use auto-injector pen for patients with severe eosinophilic asthma, according to a ...
Phillips-Medisize, in collaboration with its customer, Ascendis Pharma, was recently recognized with a third industry award for the Skytrofa Auto-Injector. The Red Dot Award recognizes the drug ...
The global auto-injectors market is on a significant growth trajectory, with market share expected to reach a robust valuation of USD 30,578.2 million in 2023. This figure represents a strong presence ...
Innovative product development firm Cambridge Consultants has developed a new auto-injector to deliver viscous progesterone in oil (PiO) hormonal injections in women undergoing in vitro fertilisation ...
Epinephrine Injection (Auto-Injector) is a prescription medicine in a disposable, prefilled automatic injection device (auto-injector) used to treat life-threatening, allergic emergencies including ...
Meridian Medical has made available Alsuma (sumatriptan injection auto-injector), a selective 5-HT1B/1D receptor agonist, for the acute treatment of migraine attacks, with or without aura, and the ...
The Prefilled Auto Injectors Market is poised for robust expansion driven by escalating incidence of chronic conditions, heightened demand for self-administration therapeutics, and intensifying focus ...